Overview

Glivec in Ph Positive Lymphoblastic Leukemia

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
% positive Ph LLA with RC alter the Glivec and induction chemotherapy treatment
Phase:
Phase 2
Details
Lead Sponsor:
PETHEMA Foundation
Treatments:
Imatinib Mesylate